Vanda Pharmaceuticals reported $40.85M in Selling and Administration Expenses for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Acadia Pharmaceuticals ACAD:US $ 96.68M 9.23M
Acorda Therapeutics ACOR:US $ 25.44M 1.6M
Agios Pharmaceuticals AGIO:US $ 31.51M 13K
Akebia Therapeutics AKBA:US $ 44.33M 498K
Alnylam Pharmaceuticals ALNY:US $ 154.47M 31.91M
Anika Therapeutics ANIK:US $ 19.2M 1.23M
Arrowhead Research ARWR:US $ 33.86M 9.27M
AstraZeneca AZN:LN 3.06B 1.03B
Bristol Myers Squibb BMY:US $ 1.83B 523M
Clovis Oncology CLVS:US $ 29.21M 4.13M
Eli Lilly And LLY:US $ 1.56B 34.1M
Enanta Pharmaceuticals ENTA:US $ 10.48M 968K
Esperion Therapeutics ESPR:US $ 30.38M 5.29M
Halozyme Therapeutics HALO:US $ 13.83M 60K
Heron Therapeutics HRTX:US $ 32.96M 1.42M
Insmed INSM:US $ 56.75M 8.52M
Intercept Pharmaceuticals ICPT:US $ 50.01M 10.58M
Johnson & Johnson JNJ:US $ 5.94B 1.22B
Lexicon Pharmaceuticals LXRX:US 8.49M 355K
Ligand Pharmaceuticals LGND:US $ 18.18M 444K
Merk MRK:US $ 2.3B 518M
Minerva Neurosciences NERV:US $ 3.03M 398.63K
Moderna Inc MRNA:US 268M 67M
Novartis NVS:US 3.5B 486M
Ptc Therapeutics PTCT:US $ 73.27M 13.28M
Puma Biotechnology PBYI:US $ 20.4M 2.06M
Sangamo Biosciences SGMO:US $ 14.91M 1.18M
Takeda 4502:JP 223.43B 7.65B
Teva Pharmaceutical TEVA:IT 819M 39M
Ultragenyx Pharmaceutical RARE:US $ 67.31M 7.88M
Vanda Pharmaceuticals VNDA:US $ 40.85M 7.4M
Veracyte VCYT:US $ 44.14M 15.82M